Skip to main content

Webinar: Hyperosmolar hyperglycaemic state (HHS) – so what’s new in the latest JBDS guidelines?

Hyperosmolar hyperglycaemic state (HHS) – so what’s new in the latest JBDS guidelines?
Thursday 9th June 2022, 5:00pm - 6:00pm

In the fifth of our 2022 ABCD webinar series, please join Dr Dr Masud Haq who will be discussing the new hyperosmolar hyperglycaemic state (HHS) guidelines that were published in February 2022 by the Joint British Diabetes Societies (JBDS) for Inpatient Care group.

Although HHS is less common than diabetic ketoacidosis (DKA), it is associated with a higher mortality.  Recent evidence demonstrates mixed HHS and DKA is not only common but patients fare worse. The updated guidelines will improve the early recognition of these cases. With the aid of illustrated scenarios, previous areas of uncertainty are covered including the early initiation of fixed rate iv insulin infusions; the introduction of new exit criteria; bedside charts and pathways.

Q& A will follow this presentation

RCP Accreditation has been sought for this webinar.  Certificates of attendance will be issued to those who attend the live webinar.

 

On Demand

is meeting has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 1 category 1 (external) credit (ref: 136286)